Line 18: |
Line 18: |
| !'''Date of Last Editor Review''' | | !'''Date of Last Editor Review''' |
| !'''Notes''' | | !'''Notes''' |
− | |- |Usual ductal hyperplasia||Disease|| | + | |- |
− | |Usual Ductal Hyperplasia | + | |CHAPTER 2 (TUMOURS OF THE CONJUCTIVA AND CARUNCLE) |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | |- |
| + | |[[EYE5:Epithelial_conjunctival_inclusion_cyst|Epithelial conjunctival inclusion cyst]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Reactive_epithelial_hyperplasia_of_the_conjunctiva|Reactive epithelial hyperplasia of the conjunctiva]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Papillary_and_follicular_conjunctivitis|Papillary and follicular conjunctivitis]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Pterygium_and_pingueculum|Pterygium and pingueculum]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Epibulbar_choristoma_(dermoid;_dermolipoma;_complex_choristoma)|Epibulbar choristoma (dermoid; dermolipoma; complex choristoma)]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Epibulbar_osseous_choristoma|Epibulbar osseous choristoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Conjunctival_squamous_cell_papilloma|Conjunctival squamous cell papilloma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Conjunctival_oncocytoma|Conjunctival oncocytoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Hereditary_benign_intraepithelial_dyskeratosis|Hereditary benign intraepithelial dyskeratosis]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Conjunctival_squamous_intraepithelial_neoplasia|Conjunctival squamous intraepithelial neoplasia]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Conjunctival_squamous_cell_carcinoma|Conjunctival squamous cell carcinoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Adenosquamous_carcinoma|Adenosquamous carcinoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Benign_epithelial_melanosis_of_the_conjunctiva|Benign epithelial melanosis of the conjunctiva]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Junctional,_compound_and_subepithelial_conjunctival_naevi|Junctional, compound and subepithelial conjunctival naevi]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Inflamed_juvenile_conjunctival_naevus|Inflamed juvenile conjunctival naevus]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Blue_naevus_of_the_conjunctiva|Blue naevus of the conjunctiva]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:WNT-activated_deep_penetrating/plexiform_melanocytoma_(naevus)|WNT-activated deep penetrating/plexiform melanocytoma (naevus)]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Combined_naevus|Combined naevus]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Conjunctival_melanocytic_intraepithelial_lesions|Conjunctival melanocytic intraepithelial lesions]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Conjunctival_melanoma|Conjunctival melanoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |CHAPTER 3 (TUMOURS OF THE EYELID) |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | |- |
| + | |[[EYE5:Epidermal_inclusion_cyst|Epidermal inclusion cyst]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Intratarsal_cyst_|Intratarsal cyst]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Phakomatous_choristoma|Phakomatous choristoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Molluscum_contagiosum|Molluscum contagiosum]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Verruca_vulgaris|Verruca vulgaris]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Squamous_cell_papilloma|Squamous cell papilloma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Seborrheic_keratosis|Seborrheic keratosis]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Inverted_follicular_keratosis|Inverted follicular keratosis]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Actinic_keratosis|Actinic keratosis]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Basal_cell_carcinoma|Basal cell carcinoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Squamous_cell_carcinoma|Squamous cell carcinoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Merkel_cell_carcinoma|Merkel cell carcinoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Ductal_hidrocystoma|Ductal hidrocystoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Sebaceous_hyperplasia,_adenoma,_and_sebaceoma|Sebaceous hyperplasia, adenoma, and sebaceoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Syringoma|Syringoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Mixed_tumour|Mixed tumour]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Tubular_adenoma|Tubular adenoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Syringocystadenoma_papilliferum|Syringocystadenoma papilliferum]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Pilomatricoma|Pilomatricoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Trichilemmoma|Trichilemmoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Sebaceous_carcinoma|Sebaceous carcinoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Adenoid_cystic_carcinoma|Adenoid cystic carcinoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Signet-ring_cell/histiocytoid_carcinoma|Signet-ring cell/histiocytoid carcinoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Mucinous_carcinoma|Mucinous carcinoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Endocrine_mucin-producing_sweat_gland_carcinoma|Endocrine mucin-producing sweat gland carcinoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Microcystic_adnexal_carcinoma|Microcystic adnexal carcinoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Apocrine_carcinoma|Apocrine carcinoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Naevi_of_the_eyelid|Naevi of the eyelid]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Spitz_naevus|Spitz naevus]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:In-situ_cutaneous_melanoma|In-situ cutaneous melanoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Invasive_cutaneous_melanoma|Invasive cutaneous melanoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |CHAPTER 4 (TUMOURS OF THE UVEAL TRACT) |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | |- |
| + | |[[EYE5:Ectopic_tissue|Ectopic tissue]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Implantation_cyst|Implantation cyst]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Pigmented_epithelial_cyst|Pigmented epithelial cyst]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Lisch_nodule|Lisch nodule]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Ocular_melanocytosis|Ocular melanocytosis]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Iris_naevus|Iris naevus]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Iris_melanoma|Iris melanoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Choroidal_and_ciliary_body_naevi|Choroidal and ciliary body naevi]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Uveal_melanocytoma|Uveal melanocytoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Bilateral_diffuse_uveal_melanocytic_proliferation|Bilateral diffuse uveal melanocytic proliferation]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Choroidal_and_ciliary_body_melanomas|Choroidal and ciliary body melanomas]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |CHAPTER 5 (TUMOURS OF THE RETINA AND NEUROEPITHELIUM) |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | |- |
| + | |[[EYE5:Astrocytic_tumours|Astrocytic tumours]] |
| |Disease | | |Disease |
| + | | |
| + | | |
| + | | |
| | | | | |
| | | | | |
Line 27: |
Line 792: |
| | | | | |
| |- | | |- |
− | |Columnar Cell Lesions, Including Flat Epithelial Atypia||Disease|| | + | |[[EYE5:Nodular_and_massive_retinal_gliosis|Nodular and massive retinal gliosis]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 36: |
Line 803: |
| | | | | |
| |- | | |- |
− | |Atypical Ductal Hyperplasia||Disease|| | + | |[[EYE5:Retinocytoma|Retinocytoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 45: |
Line 814: |
| | | | | |
| |- | | |- |
− | |Sclerosing Adenosis||Disease|| | + | |[[EYE5:Retinoblastoma|Retinoblastoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 54: |
Line 825: |
| | | | | |
| |- | | |- |
− | |Apocrine Adenosis and Adenoma||Disease|| | + | |[[EYE5:Hamartoma_of_the_retinal_pigment_epithelium|Hamartoma of the retinal pigment epithelium]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 63: |
Line 836: |
| | | | | |
| |- | | |- |
− | |Microglandular Adenosis||Disease|| | + | |[[EYE5:Congenital_hypertrophy_of_the_retinal_pigment_epithelium|Congenital hypertrophy of the retinal pigment epithelium]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 72: |
Line 847: |
| | | | | |
| |- | | |- |
− | |Radial Scar/Complex Sclerosing Lesion||Disease|| | + | |[[EYE5:Reactive_hyperplasia_of_the_retinal_pigment_epithelium|Reactive hyperplasia of the retinal pigment epithelium]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 81: |
Line 858: |
| | | | | |
| |- | | |- |
− | |Tubular Adenoma||Disease|| | + | |[[EYE5:Adenoma_and_adenocarcinoma_of_the_retinal_pigment_epithelium|Adenoma and adenocarcinoma of the retinal pigment epithelium]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 90: |
Line 869: |
| | | | | |
| |- | | |- |
− | |Lactating Adenoma||Disease|| | + | |[[EYE5:Reactive_epithelial_hyperplasia_of_the_ciliary_epithelium|Reactive epithelial hyperplasia of the ciliary epithelium]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 99: |
Line 880: |
| | | | | |
| |- | | |- |
− | |Ductal Adenoma||Disease|| | + | |[[EYE5:Nodular_hyperplasia_of_the_ciliary_epithelium|Nodular hyperplasia of the ciliary epithelium]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 108: |
Line 891: |
| | | | | |
| |- | | |- |
− | |Pleomorphic Adenoma||Disease|| | + | |[[EYE5:Glioneuronal_hamartoma_of_the_ciliary_body|Glioneuronal hamartoma of the ciliary body]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 117: |
Line 902: |
| | | | | |
| |- | | |- |
− | |Adenomyoepithelioma||Disease|| | + | |[[EYE5:Adenoma_and_adenocarcinoma_of_the_ciliary_body|Adenoma and adenocarcinoma of the ciliary body]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 126: |
Line 913: |
| | | | | |
| |- | | |- |
− | |Malignant Adenomyoepithelioma||Disease|| | + | |[[EYE5:Medulloepithelioma_of_the_ciliary_body|Medulloepithelioma of the ciliary body]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 135: |
Line 924: |
| | | | | |
| |- | | |- |
− | |Intraductal Papilloma||Disease|| | + | |CHAPTER 6 (TUMOURS OF THE OPTIC DISC AND OPTIC NERVE) |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| |- | | |- |
− | |Papillary Ductal Carcinoma In Situ||Disease|| | + | |[[EYE5:Optic_nerve_choristoma|Optic nerve choristoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 153: |
Line 955: |
| | | | | |
| |- | | |- |
− | |Encapsulated Papillary Carcinoma||Disease|| | + | |[[EYE5:Gliomas_of_the_optic_nerve|Gliomas of the optic nerve]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 162: |
Line 966: |
| | | | | |
| |- | | |- |
− | |Solid Papillary Carcinoma (In Situ and Invasive)||Disease|| | + | |[[EYE5:Medulloepithelioma_of_the_optic_disc_and_optic_nerve|Medulloepithelioma of the optic disc and optic nerve]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 171: |
Line 977: |
| | | | | |
| |- | | |- |
− | |Invasive Papillary Carcinoma||Disease|| | + | |[[EYE5:Meningioma_of_the_optic_nerve|Meningioma of the optic nerve]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 180: |
Line 988: |
| | | | | |
| |- | | |- |
− | |Atypical Lobular Hyperplasia||Disease|| | + | |[[EYE5:Melanocytoma_of_the_optic_disc_and_optic_nerve|Melanocytoma of the optic disc and optic nerve]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 189: |
Line 999: |
| | | | | |
| |- | | |- |
− | |Lobular Carcinoma In Situ||Disease|| | + | |CHAPTER 7 (TUMOURS OF THE LACRIMAL GLAND) |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| |- | | |- |
− | |Ductal Carcinoma In Situ||Disease|| | + | |[[EYE5:Dacryops_cyst|Dacryops cyst]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 207: |
Line 1,030: |
| | | | | |
| |- | | |- |
− | |Invasive Breast Carcinoma of No Special Type||Disease|| | + | |[[EYE5:Pleomorphic_adenoma_of_the_lacrimal_gland|Pleomorphic adenoma of the lacrimal gland]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 216: |
Line 1,041: |
| | | | | |
| |- | | |- |
− | |Microinvasive Carcinoma||Disease|| | + | |[[EYE5:Lacrimal_gland_oncocytoma|Lacrimal gland oncocytoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 225: |
Line 1,052: |
| | | | | |
| |- | | |- |
− | |Invasive lobular Carcinoma||Disease|| | + | |[[EYE5:Myoepithelioma|Myoepithelioma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 234: |
Line 1,063: |
| | | | | |
| |- | | |- |
− | |Tubular Carcinoma||Disease|| | + | |[[EYE5:Intraductal_carcinoma|Intraductal carcinoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 243: |
Line 1,074: |
| | | | | |
| |- | | |- |
− | |Cribriform Carcinoma||Disease|| | + | |[[EYE5:Carcinoma_ex_pleomorphic_adenoma|Carcinoma ex pleomorphic adenoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 252: |
Line 1,085: |
| | | | | |
| |- | | |- |
− | |Mucinous Carcinoma||Disease|| | + | |[[EYE5:Adenoid_cystic_carcinoma|Adenoid cystic carcinoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 261: |
Line 1,096: |
| | | | | |
| |- | | |- |
− | |Mucinous Cystadenocarcinoma||Disease|| | + | |[[EYE5:Primary_ductal_adenocarcinoma_of_the_lacrimal_gland|Primary ductal adenocarcinoma of the lacrimal gland]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 270: |
Line 1,107: |
| | | | | |
| |- | | |- |
− | |Invasive Micropapillary Carcinoma||Disease|| | + | |[[EYE5:Secretory_carcinoma|Secretory carcinoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 279: |
Line 1,118: |
| | | | | |
| |- | | |- |
− | |Carcinoma with Apocrine Differentiation||Disease|| | + | |[[EYE5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 288: |
Line 1,129: |
| | | | | |
| |- | | |- |
− | |Metaplastic Carcinoma||Disease|| | + | |[[EYE5:Epithelial-myoepithelial_carcinoma|Epithelial-myoepithelial carcinoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 297: |
Line 1,140: |
| | | | | |
| |- | | |- |
− | |Acinic Cell Carcinoma||Disease|| | + | |[[EYE5:Acinic_cell_carcinoma|Acinic cell carcinoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 306: |
Line 1,151: |
| | | | | |
| |- | | |- |
− | |Adenoid Cystic Carcinoma||Disease||Katherine Geiersbach / Jun Liao | + | |[[EYE5:Adenocarcinoma,_NOS|Adenocarcinoma, NOS]] |
− | |10/12/02022 | + | |Disease |
− | |11/11/2023 | + | | |
− | |COMPLETE | + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| | | | | |
− | |Hui Chen / Katherine Geiersbach
| |
− | |12/6/2023
| |
− | |2021 template added
| |
| |- | | |- |
− | |Secretory Carcinoma||Disease||Hui Chen / Morteza Seifi | + | |CHAPTER 8 (TUMOURS OF THE LACRIMAL DRAINAGE SYSTEM) |
− | |10/12/2022 | + | | |
− | |11/11/2023 | + | ---- |
− | |PENDING
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| | | | | |
− | |Katherine Geiersbach
| + | ---- |
| | | | | |
− | |2021 template added | + | ---- |
| + | | |
| + | ---- |
| |- | | |- |
− | |Mucoepidermoid Carcinoma||Disease|| | + | |[[EYE5:Papillomas_(squamous_and_inverted)|Papillomas (squamous and inverted)]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 333: |
Line 1,193: |
| | | | | |
| |- | | |- |
− | |Polymorphous Adenocarcinoma||Disease|| | + | |[[EYE5:Squamous_cell_carcinoma|Squamous cell carcinoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 342: |
Line 1,204: |
| | | | | |
| |- | | |- |
− | |Tall Cell Carcinoma with Reversed Polarity||Disease||H. Evin Gulbahce | + | |[[EYE5:Lymphoepithelial_carcinoma|Lymphoepithelial carcinoma]] |
− | |8/11/2023 | + | |Disease |
− | |10/11/2023 | + | | |
− | |COMPLETE | + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| | | | | |
− | |Katherine Geiersbach
| |
| | | | | |
− | |2021 template added
| |
| |- | | |- |
− | |Neuroendocrine Tumour||Disease|| | + | |[[EYE5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 360: |
Line 1,226: |
| | | | | |
| |- | | |- |
− | |Neuroendocrine Carcinoma||Disease|| | + | |[[EYE5:Other_salivary_gland-type_carcinomas_of_the_lacrimal_drainage_system|Other salivary gland-type carcinomas of the lacrimal drainage system]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 369: |
Line 1,237: |
| | | | | |
| |- | | |- |
− | |Hamartoma||Disease|| | + | |[[EYE5:Adenocarcinoma_NOS_of_the_lacrimal_drainage_system|Adenocarcinoma NOS of the lacrimal drainage system]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 378: |
Line 1,248: |
| | | | | |
| |- | | |- |
− | |Fibroadenoma||Disease||H. Evin Gulbahce / Patricija Zot | + | |[[EYE5:Melanoma_involving_the_lacrimal_drainage_system|Melanoma involving the lacrimal drainage system]] |
− | |8/11/2023 | + | |Disease |
− | |11/11/2023 | + | | |
− | |PENDING | + | | |
| + | | |
| + | | |
| + | | |
| | | | | |
| | | | | |
| | | | | |
− | |2021 template added
| |
| |- | | |- |
− | |Phyllodes Tumour||Disease||H. Evin Gulbahce / Patricija Zot / Emilie Lalonde / Katherine Geiersbach | + | |CHAPTER 9 (TUMOURS OF THE ORBIT) |
− | |8/11/2023
| + | | |
− | |11/11/2023 | + | ---- |
− | |PENDING
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| | | | | |
− | |2021 template added | + | ---- |
| + | | |
| + | ---- |
| |- | | |- |
− | |Syringomatous Tumour||Disease|| | + | |[[EYE5:Orbital_dermoid_cysts_and_other_orbital_cysts|Orbital dermoid cysts and other orbital cysts]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 405: |
Line 1,290: |
| | | | | |
| |- | | |- |
− | |Nipple Adenoma||Disease|| | + | |[[EYE5:Cavernous_vascular_malformation|Cavernous vascular malformation]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 414: |
Line 1,301: |
| | | | | |
| |- | | |- |
− | |Paget disease of the Breast||Disease|| | + | |[[EYE5:Combined_lymphatic-venous_malformation_of_the_orbit|Combined lymphatic-venous malformation of the orbit]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 423: |
Line 1,312: |
| | | | | |
| |- | | |- |
− | |Haemangioma||Disease|| | + | |[[EYE5:Orbital_venous_malformation_|Orbital venous malformation]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 432: |
Line 1,323: |
| | | | | |
| |- | | |- |
− | |Angiomatosis||Disease|| | + | |[[EYE5:Arteriovenous_malformation|Arteriovenous malformation]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 441: |
Line 1,334: |
| | | | | |
| |- | | |- |
− | |Atypical Vascular Lesions||Disease|| | + | |[[EYE5:Orbital_glial_heterotopia|Orbital glial heterotopia]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 450: |
Line 1,345: |
| | | | | |
| |- | | |- |
− | |Postradiation Angiosarcoma of the Breast||Disease|| | + | |[[EYE5:Mesenchymal_hamartoma_of_the_orbit|Mesenchymal hamartoma of the orbit]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 459: |
Line 1,356: |
| | | | | |
| |- | | |- |
− | |Primary Angiosarcoma of the Breast||Disease|| | + | |[[EYE5:Teratoma|Teratoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 468: |
Line 1,367: |
| | | | | |
| |- | | |- |
− | |Nodular Fasciitis||Disease|| | + | |[[EYE5:Yolk_sac_tumour|Yolk sac tumour]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 477: |
Line 1,378: |
| | | | | |
| |- | | |- |
− | |Myofibroblastoma||Disease|| | + | |[[EYE5:Primary_orbital_melanoma|Primary orbital melanoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 486: |
Line 1,389: |
| | | | | |
| |- | | |- |
− | |Desmoid Fibromatosis||Disease|| | + | |CHAPTER 10 (HAEMATOLYMPHOID TUMOURS) |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| |- | | |- |
− | |Inflammatory Myofibroblastic Tumour||Disease||Yajuan Liu | + | |[[EYE5:Reactive_lymphoid_hyperplasia|Reactive lymphoid hyperplasia]] |
− | |8/11/2023 | + | |Disease |
− | |11/11/2023 | + | | |
− | |COMPLETE | + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| | | | | |
− | |Katherine Geiersbach
| |
− | |12/6/2023
| |
− | |2021 template added
| |
| |- | | |- |
− | |Schwannoma||Disease|| | + | |[[EYE5:IgG4-related_disease|IgG4-related disease]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 513: |
Line 1,431: |
| | | | | |
| |- | | |- |
− | |Neurofibroma||Disease|| | + | |[[EYE5:Primary_choroidal_lymphoma|Primary choroidal lymphoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 522: |
Line 1,442: |
| | | | | |
| |- | | |- |
− | |Granular Cell Tumour||Disease|| | + | |[[EYE5:Primary_vitreoretinal_large_B-cell_lymphoma|Primary vitreoretinal large B-cell lymphoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 531: |
Line 1,453: |
| | | | | |
| |- | | |- |
− | |Leiomyoma||Disease|| | + | |[[EYE5:Extranodal_marginal_zone_lymphoma_|Extranodal marginal zone lymphoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 540: |
Line 1,464: |
| | | | | |
| |- | | |- |
− | |Leiomyosarcoma||Disease|| | + | |[[EYE5:Follicular_lymphoma|Follicular lymphoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 549: |
Line 1,475: |
| | | | | |
| |- | | |- |
− | |Lipoma||Disease|| | + | |[[EYE5:Mantle_cell_lymphoma|Mantle cell lymphoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 558: |
Line 1,486: |
| | | | | |
| |- | | |- |
− | |Angiolipoma||Disease|| | + | |[[EYE5:Chronic_lymphocytic_leukaemia/small_lymphocytic_lymphoma|Chronic lymphocytic leukaemia/small lymphocytic lymphoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 567: |
Line 1,497: |
| | | | | |
| |- | | |- |
− | |Liposarcoma||Disease|| | + | |[[EYE5:Diffuse_large_B-cell_lymphoma_|Diffuse large B-cell lymphoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 576: |
Line 1,508: |
| | | | | |
| |- | | |- |
− | |Pseudoangiomatous Stromal Hyperplasia||Disease|| | + | |[[EYE5:Plasmacytoma|Plasmacytoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 585: |
Line 1,519: |
| | | | | |
| |- | | |- |
− | |Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease|| | + | |[[EYE5:CD30_positive_lymphoproliferative_disorders|CD30 positive lymphoproliferative disorders]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 594: |
Line 1,530: |
| | | | | |
| |- | | |- |
− | |Follicular Lymphoma||Disease|| | + | |[[EYE5:T-cell_lymphomas|T-cell lymphomas]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 603: |
Line 1,541: |
| | | | | |
| |- | | |- |
− | |Diffuse Large B-cell Lymphoma||Disease|| | + | |[[EYE5:Extranodal_lymphoma_of_mature_NK_or_T-cell_lineage|Extranodal lymphoma of mature NK or T-cell lineage]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 612: |
Line 1,552: |
| | | | | |
| |- | | |- |
− | |Burkitt Lymphoma||Disease|| | + | |[[EYE5:Extramedullary_myeloid_sarcoma|Extramedullary myeloid sarcoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 621: |
Line 1,563: |
| | | | | |
| |- | | |- |
− | |Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease|| | + | |[[EYE5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 630: |
Line 1,574: |
| | | | | |
| |- | | |- |
− | |Gynaecomastia||Disease|| | + | |[[EYE5:Rosai-Dorfman_disease|Rosai-Dorfman disease]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 639: |
Line 1,585: |
| | | | | |
| |- | | |- |
− | |Carcinoma In Situ||Disease|| | + | |[[EYE5:Erdheim-Chester_disease|Erdheim-Chester disease]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 648: |
Line 1,596: |
| | | | | |
| |- | | |- |
− | |Invasive Carcinoma||Disease|| | + | |[[EYE5:Langerhans_cell_tumours|Langerhans cell tumours]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 657: |
Line 1,607: |
| | | | | |
| |- | | |- |
− | |Metastases to the Breast||Disease|| | + | |[[EYE5:Xanthelasma|Xanthelasma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 666: |
Line 1,618: |
| | | | | |
| |- | | |- |
− | |BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease||Constance Albarracin / Katherine Geiersbach | + | |[[EYE5:Adult_orbital_xanthogranulomatous_disease|Adult orbital xanthogranulomatous disease]] |
− | |12/6/2023 | + | |Disease |
− | |3/6/2024 | + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |CHAPTER 11 (SOFT TISSUE AND BONE TUMOURS) |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| | | | | |
| + | ---- |
| + | | |
| + | ---- |
| |- | | |- |
− | |Cowden Syndrome||Disease|| | + | |[[EYE5:Conjunctival_stromal_tumour_and_ocular_surface_fibroma|Conjunctival stromal tumour and ocular surface fibroma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 684: |
Line 1,660: |
| | | | | |
| |- | | |- |
− | |Ataxia-Telangiectasia||Disease||Evin Gulbahce / Katherine Geiersbach | + | |[[EYE5:Fibrous_histiocytoma|Fibrous histiocytoma]] |
− | |12/11/2023 | + | |Disease |
− | |3/11/2024 | + | | |
| + | | |
| + | | |
| + | | |
| | | | | |
| | | | | |
− | |Katherine Geiersbach
| |
| | | | | |
| | | | | |
| |- | | |- |
− | |Li-Fraumeni Syndrome, TP53-Associated||Disease|| | + | |[[EYE5:Nodular_and_proliferative_fasciitis,_proliferative_myositis|Nodular and proliferative fasciitis, proliferative myositis]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 702: |
Line 1,682: |
| | | | | |
| |- | | |- |
− | |Li-Fraumeni Syndrome, CHEK2-Associated||Disease|| | + | |[[EYE5:Solitary_fibrous_tumour|Solitary fibrous tumour]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 711: |
Line 1,693: |
| | | | | |
| |- | | |- |
− | |CDH1-Associated Breast Cancer||Disease|| | + | |[[EYE5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 720: |
Line 1,704: |
| | | | | |
| |- | | |- |
− | |PALB2-Associated Cancers||Disease||Constance Albarracin / Katherine Geiersbach | + | |[[EYE5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]] |
− | |12/8/2023 | + | |Disease |
− | |3/8/2024 | + | | |
| + | | |
| + | | |
| | | | | |
| | | | | |
Line 729: |
Line 1,715: |
| | | | | |
| |- | | |- |
− | |Peutz-Jeghers Syndrome||Disease|| | + | |[[EYE5:Angiomyxoma|Angiomyxoma]] |
| + | |Disease |
| + | | |
| | | | | |
| | | | | |
Line 738: |
Line 1,726: |
| | | | | |
| |- | | |- |
− | |Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova | + | |[[EYE5:Benign_lipomatous_tumours|Benign lipomatous tumours]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Malignant_adipocytic_tumours|Malignant adipocytic tumours]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Rhabdomyosarcoma_family|Rhabdomyosarcoma family]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Leiomyoma|Leiomyoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Mesectodermal_leiomyoma|Mesectodermal leiomyoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Leiomyosarcoma|Leiomyosarcoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Schwannoma|Schwannoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Neurofibroma|Neurofibroma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Granular_cell_tumour|Granular cell tumour]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Masson_tumour|Masson tumour]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Infantile_haemangioma|Infantile haemangioma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Lobular_capillary_haemangioma|Lobular capillary haemangioma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Lymphangiectasia|Lymphangiectasia]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Epithelioid_haemangioma|Epithelioid haemangioma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Haemangioblastoma|Haemangioblastoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Angiosarcoma|Angiosarcoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Glomus_tumour|Glomus tumour]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:PEComa|PEComa]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Epithelioid_sarcoma|Epithelioid sarcoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Synovial_sarcoma|Synovial sarcoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Osteoma|Osteoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Osteoblastoma|Osteoblastoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Osteosarcoma|Osteosarcoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Soft_tissue_chondroma|Soft tissue chondroma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Fibrous_dysplasia|Fibrous dysplasia]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Haemangioma_of_bone|Haemangioma of bone]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Angiosarcoma_of_bone|Angiosarcoma of bone]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Giant_cell_tumour_of_bone|Giant cell tumour of bone]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Ewing_sarcoma|Ewing sarcoma]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |CHAPTER 12 (METASTASES TO THE EYE AND SURROUNDING STRUCTURES) |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | |- |
| + | |[[EYE5:Metastases_to_ocular_adnexal_structures|Metastases to ocular adnexal structures]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Metastases_to_intra-ocular_structures|Metastases to intra-ocular structures]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |CHAPTER 13 (GENETIC TUMOUR SYNDROMES) |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | |- |
| + | |[[EYE5:Retinoblastoma_syndrome|Retinoblastoma syndrome]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Von_Hippel_Lindau_syndrome|Von Hippel Lindau syndrome]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Sturge_Weber_syndrome|Sturge Weber syndrome]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]] |
| + | |Disease |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |[[EYE5:Goldenhar_syndrome|Goldenhar syndrome]] |
| + | |Disease |
| + | | |
| + | | |
| | | | | |
| | | | | |
Line 745: |
Line 2,249: |
| | | | | |
| | | | | |
− | |NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
| |
| |- | | |- |
− | |Polygenic Component of Breast Cancer Susceptibility | + | |[[EYE5:Muir-Torre_syndrome|Muir-Torre syndrome]] |
| |Disease | | |Disease |
| | | | | |